San Diego-primarily based Viking Therapeutics marked itself as a serious competitor from the weight loss drug industry in February just after revealing promising info from the mid-stage trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when specified as being a weekly injection As well as in Ma